- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 487/10 - Spiro-condensed systems
Patent holdings for IPC class C07D 487/10
Total number of patents in this class: 2088
10-year publication summary
|
113
|
133
|
174
|
137
|
150
|
192
|
213
|
211
|
189
|
137
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Hoffmann-La Roche Inc. | 3832 |
53 |
| Boehringer Ingelheim International GmbH | 4488 |
48 |
| Bristol-myers Squibb Company | 4757 |
47 |
| F. Hoffmann-La Roche AG | 7796 |
47 |
| Novartis AG | 10174 |
32 |
| Enanta Pharmaceuticals, Inc. | 426 |
32 |
| Janssen Pharmaceutica N.V. | 3150 |
31 |
| The Regents of the University of Michigan | 5030 |
31 |
| Tenacia Biotechnology (Hong Kong) Co., Limited | 36 |
30 |
| Amgen Inc. | 4445 |
26 |
| Takeda Pharmaceutical Company Limited | 2698 |
26 |
| Merck Sharp & Dohme LLC | 3734 |
26 |
| Merck Patent GmbH | 5742 |
25 |
| Gilead Sciences, Inc. | 2243 |
25 |
| The Regents of the University of California | 20868 |
24 |
| Daiichi Sankyo Company, Limited | 1889 |
21 |
| Araxes Pharma LLC | 90 |
19 |
| AstraZeneca AB | 2817 |
18 |
| Arvinas Operations, Inc. | 247 |
18 |
| Pfizer Inc. | 3414 |
17 |
| Other owners | 1492 |